ESMO 2022 Conference Coverage

 

ESMO 2022 Conference Coverage
D

ESMO 2022: Should All Advanced Ovarian Cancer Patients Receive a PARPi in 1L Therapy?

By ESMO 2022 Conference Coverage FEATURING David Tan
By ESMO 2022 Conference Coverage FEATURING David Tan
794 views
September 19, 2022
Comments 0
Login to view comments. Click here to Login
GYN
08:47

ESMO 2022 on the SOLO1/GOG-3004 Trial: OS at 7-Year Follow-Up in Pat…

ESMO 2022 Conference Coverage

P. DiSilvestro

231 views
09:44

ESMO 2022 on the Randomized Phase 3 FORWARD I Study: Analyses of Pat…

ESMO 2022 Conference Coverage

K. Moore

665 views
18:57

ESMO 2022: Should All Advanced Ovarian Cancer Patients Receive a PAR…

ESMO 2022 Conference Coverage

D. Tan

794 views